Norethindrone Acetate combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Breast Cancer Other Serious 2/2/2004 54 Female 115 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/3/2000 65 Female 147 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/4/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2004 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/1999 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2000 64 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/20/2000 64 Female 198 lb 12/23/2005 United States
Primary
Secondary
Seroma Other Serious 11/4/2003 47 Female 6/16/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/20/1996 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/5/2004 60 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/1997 72 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2001 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1996 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/18/2004 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/25/1997 Female 2/5/2007 Consumer United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 4/30/2003 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/27/2004 75 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/17/2000 61 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/5/2004 59 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2000 62 Female 145 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2001 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/25/2004 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/25/1997 Female 6/15/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/25/1997 Female 7/3/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 4/25/1997 Female 8/22/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 6/11/1999 Female 10/8/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/27/1999 Female 10/19/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 5/17/1996 Female 12/11/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/21/1998 Female 12/12/2007 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/4/2003 Female 1/8/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2004 64 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2000 62 Female 145 lb 12/18/2007 United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/2004 Female 12/18/2007 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 11/4/2003 Female 3/3/2008 Consumer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 5/3/1996 Female 3/3/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/25/1997 Female 3/4/2008 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/7/2001 Female 180 lb 3/6/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/8/1999 Female 4/14/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/21/2003 Female 4/14/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2001 Female 5/2/2008 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 12/1/1998 Female 5/5/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/1/2000 Female 5/7/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/8/1999 Female 5/15/2008 Consumer United States
Primary
Secondary
Lung Cancer Metastatic Other Serious 5/5/1999 Female 175 lb 5/20/2008 Lawyer United States
Primary
Secondary
Lung Cancer Metastatic Other Serious 5/5/1999 Female 175 lb 6/12/2008 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 6/24/2008 Consumer United States
Primary
Secondary
Seroma Other Serious 11/4/2003 Female 7/1/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/4/2003 Female 7/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/4/2003 Female 8/11/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/25/1997 Female 9/3/2008 Consumer United States
Primary
Secondary
Concomitant
Breast Disorder Other Serious Female 9/11/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 5/2/1996 Female 9/11/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/25/1997 Female 9/22/2008 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 7/8/1999 Female 10/21/2008 Consumer United States
Primary
Secondary
Ventricular Dysfunction Other Serious 4/25/1997 Female 10/23/2008 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/23/1995 61 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2002 55 Female 150 lb 10/9/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/20/1996 48 Female 10/9/2008 United States
Primary
Secondary
Paget's Disease Of The Breast Other Serious 9/16/2003 Female 11/5/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/9/1995 56 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/2/1995 59 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/29/1996 63 Female 160 lb 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2000 48 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/9/1996 56 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 75 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/16/1999 67 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/18/2004 57 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/12/2001 52 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/14/1997 63 Female 10/9/2008 United States
Primary
Secondary
Paget's Disease Of The Breast Other Serious 9/16/2003 Female 11/20/2008 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/6/2004 76 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/17/2000 56 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/6/2002 61 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Disorder Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Disorder Other Serious Female 12/19/2008 United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 4/28/2003 73 Female 12/19/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Cerebrovascular Accident Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Disorder Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/25/2004 58 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 4/27/2004 75 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2000 55 Female 12/19/2008 United States
Primary
Secondary
Lung Neoplasm Malignant Other Serious 1/22/1999 Female 2/6/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/13/2004 Female 2/12/2009 Consumer United States
Primary
Secondary
Cutaneous Lupus Erythematosus Other Serious 1/1/2004 Female 2/13/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/14/2002 66 Female 12/19/2008 United States
Primary
Secondary
Breast Disorder Other Serious 12/11/1992 Female 2/23/2009 Consumer United States
Primary
Secondary
Pleural Effusion Other Serious 1/1/2003 Female 3/26/2009 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 12/1/1998 Female 3/30/2009 Consumer United States
Primary
Secondary
Malignant Neoplasm Progression Other Serious 11/28/2005 Female 4/1/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/24/2003 Female 4/3/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 3/24/2003 Female 4/8/2009 Consumer United States
Primary
Secondary
Lung Neoplasm Malignant Other Serious 1/22/1999 Female 6/2/2009 Consumer United States
Primary
Secondary
Vena Cava Thrombosis Other Serious 7/1/2003 48 Female 6/9/2009 United States
Primary
Secondary
Lung Cancer Metastatic Other Serious 5/5/1999 Female 175 lb 6/23/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 1/1/1992 Female 10/1/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/27/2004 Female 10/1/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/21/2003 Female 10/29/2009 Consumer United States
Primary
Secondary
Lung Neoplasm Malignant Other Serious 1/22/1999 Female 11/9/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/2/2000 60 Female 145 lb 5/5/2010 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 8/2/2000 60 Female 145 lb 5/7/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/27/2004 75 Female 5/11/2010 Consumer United States
Primary
Secondary
Lung Neoplasm Malignant Other Serious 1/1/2001 66 Female 6/2/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/7/2001 54 Female 180 lb 6/8/2010 Consumer United States
Primary
Secondary
Lung Neoplasm Malignant Other Serious 1/1/2001 66 Female 7/12/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/7/2001 54 Female 180 lb 7/19/2010 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/9/2000 56 Female 8/11/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/7/2001 54 Female 180 lb 8/12/2010 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/9/2000 56 Female 8/20/2010 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/9/2000 56 Female 8/27/2010 Lawyer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 6/25/2002 55 Female 150 lb 9/7/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/20/1996 48 Female 9/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/23/1995 61 Female 9/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 9/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/14/2005 48 Female 9/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/22/1995 61 Female 9/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2000 52 Female 9/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2000 54 Female 9/16/2010 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/2/2004 54 Female 115 lb 9/17/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/18/2004 60 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 7/17/2000 56 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/2/2000 60 Female 145 lb 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 54 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 52 Female 210 lb 9/17/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/7/2008 58 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/8/2006 62 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/28/1992 47 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 9/29/2006 59 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/25/2006 62 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Disorder Other Serious 8/31/2001 52 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/17/2007 65 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Disorder Other Serious 9/8/2005 55 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/7/2001 53 Female 9/17/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1999 66 Female 9/17/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/15/2002 53 Female 9/17/2010 Lawyer United States
Primary
Secondary

Drug Data